The main cause of the fall was probably due to Novartis and Sequirus businesses not performing to expectations. Subsequently this has been rectified and the two businesses are humming along quite nicely.
Ann: Half Year Results Analyst Presentation, page-129
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.56 |
Change
1.960(0.64%) |
Mkt cap ! $149.1B | |||
| Open | High | Low | Value | Volume |
| $308.93 | $311.00 | $306.28 | $198.7M | 643.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 859 | $308.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.65 | 5 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |